Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Seeger

Showing results (441-450 of 454) with videos related to

Pageof 46
Sort By:
The European Respiratory Journal|August 11, 2007
Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertensionF Reichenberger, R Voswinckel, B Enke, et al.
Oncogene|April 25, 2012
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIFS S Pullamsetti, G A Banat, A Schmall, et al.
Journal of the American Academy of Dermatology|April 29, 1998
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trialP Mayser, U Mrowietz, P Arenberger, et al.
The European Respiratory Journal|November 18, 2008
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxiaK Woyda, S Koebrich, I Reiss, et al.
The European Respiratory Journal|October 16, 2010
Terguride ameliorates monocrotaline-induced pulmonary hypertension in ratsR Dumitrascu, C Kulcke, M Königshoff, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2000
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsiesR A Jörres, O Holz, W Zachgo, et al.
The European Respiratory Journal|June 10, 2010
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertensionB K Dahal, D Kosanovic, P K Pamarthi, et al.
Chest|March 15, 2002
Primary pulmonary hypertension is predominantly a hereditary diseaseE Grünig, D Mereles, K Arnold, et al.
Pulmonary Circulation|September 28, 2018
Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertensionN Sommer, F Droege, K E Gamen, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]H Olschewski, J Behr, H Bremer, et al.
Pageof 46

Showing results (441-450 of 454) with videos related to

Sort By:
Pageof 46
The European Respiratory Journal|August 11, 2007
Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertensionF Reichenberger, R Voswinckel, B Enke, et al.
Oncogene|April 25, 2012
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIFS S Pullamsetti, G A Banat, A Schmall, et al.
Journal of the American Academy of Dermatology|April 29, 1998
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trialP Mayser, U Mrowietz, P Arenberger, et al.
The European Respiratory Journal|November 18, 2008
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxiaK Woyda, S Koebrich, I Reiss, et al.
The European Respiratory Journal|October 16, 2010
Terguride ameliorates monocrotaline-induced pulmonary hypertension in ratsR Dumitrascu, C Kulcke, M Königshoff, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2000
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsiesR A Jörres, O Holz, W Zachgo, et al.
The European Respiratory Journal|June 10, 2010
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertensionB K Dahal, D Kosanovic, P K Pamarthi, et al.
Chest|March 15, 2002
Primary pulmonary hypertension is predominantly a hereditary diseaseE Grünig, D Mereles, K Arnold, et al.
Pulmonary Circulation|September 28, 2018
Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertensionN Sommer, F Droege, K E Gamen, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]H Olschewski, J Behr, H Bremer, et al.
Pageof 46